FDA Approved: * September 4, 2018 Pharm Company: *WATSON LABS Category:Heart (Cardiac)
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. The drug is produced by AstraZeneca.
90mg tablet of Brilinta
It was approved for medical use in the European Union in December 2010,&...
* May have multiple approval dates, manufacturers, or labelers. 5 Discussions